Test Bank - Clayton’s Basic Pharmacology for Nurses, 19th edition (Willihnganz, 2023)

Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition
By Michelle J. Willihnganz, Samuel L. Gurevitz, Bruce Clayton
Complete

,Chapterwk01:wkDrugwkDefinitions,wkStandards,wkandwkInformationwkSourceswk
Willihnganz:wkClayton’swkBasicwkPharmacologywkforwkNurses,wk19thwkEdition


MULTIPLEwkCHOIC
E

1. WhichwknamewkidentifieswkawkdrugwklistedwkbywkthewkUS
wkFoodwkandwkDrugwkAdministrationwk(FDA)?
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS:wkC
Thewkofficialwknamewkiswkthewknamewkunderwkwhichwkawkdr
ugwkiswklistedwkbywkthewkFDA.wkThewkbrandwkname,wkorwktr
ademark,wkiswkthewknamewkgivenwktowkawkdrugwkbywkitswkm
anufacturer.wkThewknonproprietary,wkorwkgeneric,wknamewkis
wkprovidedwkbywkthewkUnitedwkStateswkAdoptedwkNameswkC
DIF: CognitivewkLevel:wkKnowledge
ouncil. REF:wkp.wk9
OBJ:wk1NAT:wkNCLEXwkClientwkNeedswkCategory:wkSafe,wkEff
ectivewkCarewkEnvironmentwkTOP:w k NursingwkProcesswkStep:wkAssess
ment
CON:
wkPatientwkEducation


2. Whichwksourcewkcontainswkinformationwkspecificwktowknutritionalsupplements?
a. USPwkDictionarywkofwkUSANwk&wkInternationalwkDrugwkNames
b. NaturalwkMedicineswkComprehensivewkDatabase
c. UnitedwkStateswkPharmacopoeia/NationalwkFormularywk(USPNF)
d. DrugwkInteractionwkFacts
ANS:wkC
UnitedwkStateswkPharmacopoeia/NationalwkFormularywkcontainswkinformationwkspecificwktowk
nutritionalwksupplements.wkUSPwkDictionarywkofwkUSANwk&wkInternationalwkDrugwkNameswki
swkawkcompilationwkofwkdrugwknames,wkpronunciationwkguide,wkandwkpossiblewkfuturewkFDAw
kapprovedwkdrugs;wkitwkdoeswknotwkincludewknutritionalwksupplements.wkNaturalwkMedicinesw
kComprehensivewkDatabasewkcontains
evidence-
basedwkinformationwkonwkherbalwkmedicineswkandwkherbalwkcombinationwkproducts;wkitwkdoes
wknotwkincludewkinformationwkspecificwktowknutritionalwksupplements.wkDrugwkInteractionwkF
actswkcontainswkcomprehensivewkinformationwkonwkdrugwkinteractionwkfacts;wkitwkdoeswknotwk
includewknutritionalwksupplements.

DIF: CognitivewkLevel:wkKnowledge REF:w k p.wk4
OBJ:wk3wkNAT:wkNCLEXwkClientwkNeedswkCategory:wkPhysiolo
gicalwkIntegrity
TOP:w k NursingwkProcesswkStep:wkAssessment CON:wkNutritionwk|wkPatientwkEducation

3. Whichwkdrugwkreferencewkcontainswkdrugwkmonographswkthatwkdescribewkallwkdrugswkinwkawktherapeuti
cwkclass?
a. DrugwkFactswkandwkComparisons

, b. DrugwkInteractionwkFacts
c. HandbookwkonwkInjectablewkDrugs
d. Martindale—ThewkCompletewkDrugwkReference
ANS:wkA
DrugwkFactswkandwkComparisonswkcontainswkdrugwkmonographswkthatwkdescribewkall
wkdrugswkinwkawktherapeuticwkclass.wkMonographswkarewkformattedwkaswktableswktowka
llowwkcomparisonwkofwksimilarwkproducts,wkbrandwknames,wkmanufacturers,wkcostwki
ndices,wkandwkavailablewkdosagewkformswkOnlinewkversionwkiswkavailable.

DIF: CognitivewkLevel:wkKnowledge REF:wkp.wk4wkTablewk1.2
OBJ:w k w k 3 NAT:wkNCLEXwkClientwkNeedswkCategory:wkPhysiologicalwkIntegrity
TOP:w k NursingwkProcesswkStep:wkAssessment
CON:wkSafetywk|wkPatientwkEducationwk|wkClinicalwkJudgment

4. Whichwkdrugwkreferencewkcontainswkmonographswkaboutwkvirtuallywkeverywksingle-
entitydrugwkavailablewkinwkthewkUnitedwkStateswkandwkdescribeswktherapeuticwkuseswkofwkdr
ugs,wkincludingwkapprovedwkandwkunapprovedwkuses?
a. Martindale:wkThewkCompletewkDrugwkReference
b. AHFSwkDrugwkInformation
c. DrugwkReference
d. DrugwkFactswkandwkComparisons
ANS:wkB
AHFSwkDrugwkInformationwkcontainswkmonographswkaboutwkvirtuallywkeverywksingle-
entitywkdrugwkavailablewkinwkthewkUnitedwkStateswkandwkdescribeswktherapeuticwkuseswkofwkdr
ugs,wkincludingwkapprovedwkandwkunapprovedwkuses.

DIF: CognitivewkLevel:wkKnowledge REF:wkp.wk4wkTablewk1.2
OBJ:w k w k 3 NAT:wkNCLEXwkClientwkNeedswkCategory:wkPhysiologicalwkIntegrity
TOP:w k NursingwkProcesswkStep:wkPlanning CON:wkSafetywk|wkPatientwkEducationwk|wkClinicalwkJudgment

5. Whichwkonlinewkdrugwkreferencewkmakeswkavailablewktowkhealthcarewkproviderswkandwkth
ewkpublicwkawkstandard,wkcomprehensive,wkup-to-
datewklookwkupwkandwkdownloadablewkresourcewkaboutwkmedicines?
a. AmericanwkDrugwkIndex
b. AmericanwkHospitalwkFormulary
c. DailyMed
d. DrugwkReference
ANS:wkC
DailyMedwkmakeswkavailablewktowkhealthcarewkproviderswkandwkthewkpublicwkawkstandard,wk
comprehensive,wkup-to-
datewklookwkupwkandwkdownloadablewkresourcewkaboutwkmedicines.wkThewkAmericanwkDrugw
kIndexwkiswknotwkappropriatewkforwkpatientwkuse.wkThewkAmericanwkHospitalwkFormularywkis
wknotwkappropriatewkforwkpatientwkuse.wkThewkdrugwkreferencewkiswknotwkappropriatewkforwkp
atientwkuse.

DIF: CognitivewkLevel:wkKnowledge REF:w k p.wk3wk|p.wk4
OBJ:wk3wkNAT:wkNCLEXwkClientwkNeedswkCategory:wkPhysiolo
gicalwkIntegrity
TOP:wkNursingwkProcesswkStep:wkImplementation
CON:wkSafetywk|wkPatientwkEducationwk|wkClinicalwkJudgment

6. WhichwklegislationwkauthorizeswkthewkFDAwktowkdeterminewkthewksafetywkofwkawkdrugwkbeforewkitswkma
rketing?
a. FederalwkFood,wkDrug,wkandwkCosmeticwkActwk(1938)
b. DurhamwkHumphreywkAmendmentwk(1952)

, c. ControlledwkSubstanceswkActwk(1970)
d. KefauverwkHarriswkDrugwkAmendmentwk(1962)

ANS:wkA
ThewkFederalwkFood,wkDrug,wkandwkCosmeticwkActwkofwk1938wkauthorizedwkthewkFDAwktowk
determinewkthewksafetywkofwkallwkdrugswkbeforewkmarketing.wkLaterwkamendmentswkandwkacts
wkhelpedwktightenwkFDAwkcontrolwkandwkensurewkdrugwksafety.wkThewkDurhamwkHumphreywk
Amendmentwkdefineswkthewkkindswkofwkdrugswkthatwkcannotwkbewkusedwksafelywkwithoutwkme
dicalwksupervisionwkandwkrestrictswktheirwksalewktowkprescriptionwkbywkawklicensedwkpractition
er.wkThewkControlledwkSubstanceswkActwkaddresseswkonlywkcontrolledwksubstanceswkandwkthei
rwkcategorization.wkThewkKefauverwkHarriswkDrugwkAmendmentwkensureswkdrugwkefficacywka
ndwkgreaterwkdrugwksafety.wkDrugwkmanufacturerswkarewkrequiredwktowkprovewktowkthewkFDA
wkthewkeffectivenesswkofwktheirwkproductswkbeforewkmarketingwkthem.


DIF: CognitivewkLevel:wkKnowledge REF:wkp.wk5wkTablewkl.3
OBJ:w k 5
NAT:wkNCLEXwkClientwkNeedswkCategory:wkPhysiologicalwk
IntegritywkTOP:wkNursingwkProcesswkStep:wkAssessment
CON:wkSafetywk|wkPatientwkEducationwk|wkEvidencewk|wkHealthwkCarewkLaw

7. Whichwkclassificationwkdoeswkmeperidinewk(Demerol)wkfallwkunder?
a. I
b. II
c. III
d. IV
ANS:wkB
Meperidinewk(Demerol)wkiswkawkSchedulewkIIwkdrug;wkitwkhaswkawkhighwkpotentialwkforwkabus
ewkandwkmaywkleadwktowkseverewkpsychologicalwkandwkphysicalwkdependence.wkSchedulewkIwk
drugswkhavewkhighwkpotentialwkforwkabusewkandwknowkrecognizedwkmedicalwkuse.wkSchedulewk
IIIwkdrugswkhavewksomewkpotentialwkforwkabuse.wkUsewkmaywkleadwktowklowwktowkmoderatewk
physicalwkdependencewkorwkhighwkpsychologicalwkdependence.wkSchedulewkIVwkdrugswkhave
wklowwkpotentialwkforwkabuse.wkUsewkmaywkleadwktowklimitedwkphysicalwkorwkpsychologicalwk
dependence.

DIF: CognitivewkLevel:wkKnowledge REF:w k p.wk10
OBJ:wk2wkNAT:wkNCLEXwkClientwkNeedswkCategory:wkSafe,wkE
ffectivewkCarewkEnvironment
TOP:w k NursingwkProcesswkStep:wkAssessment CON:wkPatientwkEducationwk|wkAddictionwk|wkPain

8. WhichwkactionwkwouldwkthewkFDAwktakewktowkexpeditewkdrugwkdevelopmentwkandwkapprovalw
kforwkanwkoutbreakwkofwksmallpox?
a. Listwksmallpoxwkaswkawkhealthwkorphandisease.
b. Omitwkthewkpreclinicalwkresearchphase.
c. Extendwkthewkclinicalwkresearchwkphase.
d. Fastwktrackwkthewkinvestigationalwkdrug.
ANS:wkD
OncewkthewkInvestigationalwkNewwkDrugwkApplicationwkhaswkbeenwkapproved,wkthewkdrugwk
canwkreceivewkhighestwkprioritywkwithinwkthewkagency,wkwhichwkiswkcalledwkfastwktracking.wk
Awksmallpoxwkoutbreakwkwouldwkbecomewkawkprioritywkconcernwkinwkthewkworld.wkOrphanw
kdiseaseswkarewknotwkresearchedwkinwkawkprioritywkmanner.wkPreclinicalwkresearchwkiswknotwk
omitted.wkExtendingwkanywkphasewkofwkthewkresearchwkwouldwkmeanwkawklongerwktimewktowkd
evelopwkawkvaccine.wkThewkFDAwkmustwkensurewkthatwkallwkphaseswkofwkthewkpreclinicalwkand
wkclinicalwkresearchwkphasewkhavewkbeenwkcompletedwkinwkawksafewkmanner.


DIF: CognitivewkLevel:wkKnowledge REF:w k w k p.wk7 OBJ:wk 5